In patients with bladder cancer receiving intravesical chemotherapy after tumor resection, early relapse can be observed in patients with a BCL-2/BAX ratio > 1 and a p53 gene mutation [62]. The gene discussed is BCL2; the disease is urinary bladder carcinoma.